Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
assigned, auristatin, avenue, bone, broaden, categorized, CI, competitor, complement, confidence, consecutive, decision, deepen, distinct, docetaxel, flat, hazard, HR, interval, line, modality, moderately, modification, monomethyl, newly, opt, opted, orphan, path, PDUFA, poor, predefined, prognostic, randomized, ratio, reallocate, represented, shortly, territory, tisotumab, User, vedotin
Removed:
affirmative, blinded, cervical, charge, clear, cohort, collaborating, conduct, confirmed, continuing, CRADA, CRC, defense, deliver, deploy, direct, dose, dosing, EC, emerging, employed, encouraged, encouraging, endometrial, enroll, esophageal, exploration, formation, free, guiding, identified, individual, informing, intolerant, key, low, mCRPC, minimizing, negative, Notable, obtained, President, prespecified, prove, radiology, recommended, relatlimab, SCCHN, served, sharing, sourced, stable, tissue, today, triple, triplet, valuable, vested, Vice
Filing tables
Filing exhibits
Related press release
Associated EXEL transcripts
EXEL similar filings
Filing view
External links